AIG
THRX

American International Group’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

American International Group’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,060
Closed -$40.7K – 3034
2023
Q4 		$40.7K Sell
10,060
-40
-0.4% -$122 ﹤0.01% 2858
2023
Q3 		$27.2K Buy
10,100
+359
+4% +$1.41K ﹤0.01% 2948
2023
Q2 		$90.9K Buy
9,741
+1,540
+19% +$15.2K ﹤0.01% 2649
2023
Q1 		$72.8K Buy
8,201
+164
+2% +$1.61K ﹤0.01% 2596
2022
Q4 		$40K Sell
8,037
-29
-0.4% -$170 ﹤0.01% 2806
2022
Q3 		$47K Buy
8,066
+114
+1% +$806 ﹤0.01% 2829
2022
Q2 		$44K Buy
7,952
+2,238
+39% +$18.5K ﹤0.01% 2904
2022
Q1 		$66K Sell
5,714
-402
-7% -$4.3K ﹤0.01% 2748
2021
Q4 		$78K Buy
+6,116
New +$92.3K ﹤0.01% 2824

American International Group's THRX Position: Q1 2024 in Review

American International Group sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 10,060 shares — an estimated $40.7K sold.

American International Group first reported a position in THRX in Q4 2021 and held it in 9 quarters. The position peaked at $90.9K in Q2 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

  • American International Group reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • American International Group sold 10,060 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $40.7K.
  • American International Group first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • American International Group's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $90.9K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on American International Group's 13F filing for Q1 2024, filed 13 May 2024.